secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2024-01-26T23:59:59+00:00
Accession:  0001558370-24-000593
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte announces departure of Chief Scientific Officer Cenk Sumen
------------------------------------------------------------------

- Cenk Sumen, Ph.D., ended employment as Chief Scientific Officer on January 23, 2024.
- He will receive 9 months of base salary and COBRA continuation under his severance agreement.
- Sumen will remain on MaxCyte's Scientific Advisory Board.
- Severance benefits are contingent on execution of a release of claims agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000155837024000593/0001558370-24-000593-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000155837024000593/mxct-20240123x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000593

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer